IRWD
IRWD
US46333X1081
Ironwood Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
631.22M EUR
695.66M EUR
577.79M EUR
549.51M EUR
Enterprise Value
957.22M EUR
1.01B EUR
954.68M EUR
931.85M EUR
Valuation Multiples
Trailing P/E
5.03x
5.36x
5.65x
8.95x
Forward P/E
2.55x
--
--
--
Price to Sales
1.62x
1.79x
1.6x
2.15x
Price to Book
--
--
--
--
EV/Revenue
2.46x
2.6x
2.64x
3.65x
EV/EBITDA
4.02x
4.16x
4.58x
6.95x
Price to FCF (P/FCF)
5.18x
3.75x
5.15x
5.13x
EV/FCF
7.86x
5.46x
8.51x
8.7x
FCF Yield
19.3%
26.67%
19.42%
19.49%
ende